Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-20 · accession 0001162194-22-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-23 | 2022-05-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | M - OptEx | $0.00 | +42.3K | 99.1K | +74% | $0 |
| D | 2022-05-23 | 2022-05-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | F - Tax | $2.05 | -14.4K | 119.2K | -11% | -$29.6K |
| DM | 2022-05-23 | 2022-05-20 | LAB | Kreger Bradley Allen | SVP, Gbl Ops | M - OptEx | $0.00 | -42.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-20 | M | A | 2,237 | $0.00 | 96,670 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-20 | M | A | 3,125 | $0.00 | 94,433 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-20 | F | D | 14,431 | $2.05 | 119,157 | D | — | — | |
| 4 | Common | Common Stock | 2022-05-20 | M | A | 9,527 | $0.00 | 133,588 | D | — | — | |
| 5 | Common | Common Stock | 2022-05-20 | M | A | 25,000 | $0.00 | 124,061 | D | — | — | |
| 6 | Common | Common Stock | 2022-05-20 | M | A | 2,391 | $0.00 | 99,061 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2022-05-20 | M | D | 2,237 | $0.00 | 6,711 | D | — · — to — | 2,237 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. (F3) On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| 8 | Derivative | Restricted Stock Units | 2022-05-20 | M | D | 9,527 | $0.00 | 28,584 | D | — · — to — | 9,527 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. (F6) On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. |
| 9 | Derivative | Restricted Stock Units | 2022-05-20 | M | D | 25,000 | $0.00 | 25,000 | D | — · — to — | 25,000 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. (F5) On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. |
| 10 | Derivative | Restricted Stock Units | 2022-05-20 | M | D | 2,391 | $0.00 | 16,735 | D | — · — to — | 2,391 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. (F4) On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
| 11 | Derivative | Restricted Stock Units | 2022-05-20 | M | D | 3,125 | $0.00 | 0 | D | — · — to — | 3,125 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. (F2) On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter. |